{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:30Z","timestamp":1790717010537,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013589","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000}}],"reference-count":99,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013589.pub2","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:28:52Z","timestamp":1626946132000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Interventions for the management of abdominal pain in ulcerative colitis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Vassiliki","family":"Sinopoulou","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence M.","family":"Dovey","sequence":"additional","affiliation":[{"name":"College of Health, Medicine and Life Sciences; Brunel University London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology; Sidra Medicine; Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","article-title":"Effects of low FODMAP diet on symptoms, fecal microbiome,and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial","volume":"158","author":"Cox","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0002|cit2","unstructured":"Dietary Interventions in inflammatory bowel disease (IBD) http:\/\/www.isrctn.com\/ISRCTN17061468"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.17761\/1531-2054-25.1.101","article-title":"Effect of yoga-based intervention in patients with inflammatory bowel disease","volume":"25","author":"Sharma","year":"2015","journal-title":"International Journal of Yoga Therapy"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-3959(87)90043-1","article-title":"Relaxation training as a treatment for chronic pain caused by ulcerative colitis","volume":"29","author":"Shaw","year":"1987","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Yilmaz","year":"2019","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3748\/wjg.v23.i3.533","article-title":"Efficacy and safety of stellate ganglion block in chronic ulcerative colitis","volume":"23","author":"Zhao","year":"2017","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0007|cit7","unstructured":"IBD mindfulness - mindfulness for youth with Inflammatory Bowel Disease (IBD) and depression trial www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=373115&isReview=true"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0008|cit8","unstructured":"COLONiC: consequences of olive oil replacement on ulcerative colitis anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12619000150145"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0009|cit9","first-page":"184","article-title":"Effect of acupuncture and moxibustion on bowel-related discomfort of ulcerative colitis patients in remission-A pilot study","volume":"31","author":"Bae","year":"2016","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD013589.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.crohns.2014.01.018","article-title":"Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels","volume":"8","author":"Berrill","year":"2014","journal-title":"Journal of Crohn's & Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0011|cit11","first-page":"731","article-title":"Clinical research on retention enema of traditional Chinese on serum levels of inflammatory factors of ulcerative colitis patients","volume":"30","author":"Chen","year":"2015","journal-title":"Journal of Chinese Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0012|cit12","first-page":"435","article-title":"Acupuncture combined with medication for ulcerative colitis with damp-heat syndrome at active phase","volume":"35","author":"Chen","year":"2015","journal-title":"Chinese Acupuncture & Moxibustion"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-199902000-00001","article-title":"A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.","volume":"5","author":"Cohen","year":"1999","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0014|cit14","first-page":"342","article-title":"Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis.","volume":"87","author":"Collawn","year":"1992","journal-title":"American Journal of Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD013589.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"e6651","DOI":"10.1097\/MD.0000000000006651","article-title":"Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD013589.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/ecco-jcc\/jjy222.382","article-title":"P258 Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib","volume":"13","author":"Danese","year":"2019","journal-title":"Journal of Crohn's & Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0017|cit17","first-page":"A618","article-title":"Improvement of health-related quality of life in patients with chronic inflammatory bowel disease after 4 weeks of additive treatment with menthacarin-a randomized, placebo-controlled trial","volume":"4","author":"Engel","year":"2016","journal-title":"United European Gastroenterology Journal"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0018|cit18","first-page":"116","article-title":"Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis","volume":"4","author":"Faghfoori","year":"2014","journal-title":"Health Promotion Perspectives"},{"issue":"6-B(E)","key":"10.1002\/14651858.CD013589.pub2-BIB0019|cit19","article-title":"Online mindfulness intervention for inflammatory bowel disease patients: Adherence and efficacy","volume":"80","author":"Forbes","year":"2019","journal-title":"Dissertation Abstracts International: Section B: The Sciences and Engineering"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.crohns.2008.09.004","article-title":"Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study","volume":"3","author":"Gearry","year":"2009","journal-title":"Journal of Crohn's & Colitis"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD013589.pub2-BIB0021|cit21","first-page":"A246","article-title":"Induction therapy of upadacitinib is associated with improved symptoms in bowel urgency and abdominal pain for patients with ulcerative colitis: data from u-achieve","volume":"6","author":"Ghosh","year":"2018","journal-title":"United European Gastroenterology Journal"},{"issue":"Supplement_1","key":"10.1002\/14651858.CD013589.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S1873-9946(13)60164-6","article-title":"Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SC","volume":"7","author":"Gibson","year":"2013","journal-title":"Journal of Crohn's & Colitis"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00054725-200303000-00005","article-title":"Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study","volume":"9","author":"Hallert","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"8","key":"10.1002\/14651858.CD013589.pub2-BIB0024|cit24","first-page":"1188","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer","year":"1993","journal-title":"American Journal of Gastroenterology"},{"issue":"31","key":"10.1002\/14651858.CD013589.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.11569\/wcjd.v21.i31.3445","article-title":"Effects of traditional Chinese medicine combined with 5-aminosalicylic acid in treatment of ulcerative colitis","volume":"21","author":"Huang","year":"2013","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0026|cit26","unstructured":"Fermentable dietary carbohydrates as triggers of functional gut symptoms in patients with inflammatory bowel disease www.isrctn.com\/ISRCTN98226923"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0257-7941.195409","article-title":"A randomized single blind parallel group study comparing monoherbal formulation containing holarrhena antidysenterica extract with mesalamine in chronic ulcerative colitis patients.","volume":"36","author":"Johari","year":"2016","journal-title":"Ancient Science of Life"},{"issue":"12","key":"10.1002\/14651858.CD013589.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/ibd.21302","article-title":"Coping skills for reducing pain and somatic symptoms in adolescents with IBD","volume":"16","author":"McCormick","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"issue":"12","key":"10.1002\/14651858.CD013589.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/08870446.2012.691169","article-title":"Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease.","volume":"27","author":"Mizrahi","year":"2012","journal-title":"Psychology & Health"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0030|cit30","unstructured":"Osteopathy non-manipulative in patients with Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT02763293"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S582","DOI":"10.1093\/ecco-jcc\/jjx180.1045","article-title":"The effect of web-based education on disease activity, symptom management, and quality of life on patients with inflammatory bowel disease","volume":"12","author":"Ozgursoy Uran","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"98","key":"10.1002\/14651858.CD013589.pub2-BIB0032|cit32","first-page":"418","article-title":"The effect of web-based education on diseaseactivity, symptom management and quality of lifein patients with inflammatory bowel disease: a randomized-controlled study","volume":"23","author":"Ozgursoy Uran","year":"2019","journal-title":"Medical Science"},{"issue":"12","key":"10.1002\/14651858.CD013589.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis.","volume":"330","author":"Pullan","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD013589.pub2-BIB0034|cit34","first-page":"102","article-title":"Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.","volume":"21","author":"Spagnuolo","year":"2017","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"Supplement","key":"10.1002\/14651858.CD013589.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S1590-8658(16)30228-6","article-title":"Beta-glucan, inositol and digestive enzymes in patients with inflammatory bowel disease associated with irritable bowel syndrome","volume":"48","author":"Spagnuolo","year":"2016","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S1590-8658(18)30556-5","article-title":"Low-FODMAPs diet improves intestinal symptoms in IBD patients with disease remission: randomized case-control study","volume":"50","author":"Tapete","year":"2018","journal-title":"Digestive and liver disease"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/S1590-8658(19)30446-3","article-title":"Low- versus high- FODMAPs diet in controlling residual abdominal symptoms in inflammatory bowel disease patients: a randomised controlled study with crossing over","volume":"51","author":"Tapete","year":"2019","journal-title":"Digestive and Liver Disease"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S799","DOI":"10.1016\/S0016-5085(17)32763-4","article-title":"Development and piloting of a cognitive-behavioral selfmanagement program for patients with inflammatory bowel disease: an early stage update","volume":"152","author":"Tripp","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0039|cit39","unstructured":"Transcranial direct current stimulation to reduce chronic pain in patients with chronic inflammatory bowel diseases www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS0000585"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0040|cit40","unstructured":"Transcranial direct current stimulation to reduce chronic pain in patients with chronic inflammatory bowel diseases (tDCS in IBD) clinicaltrials.gov\/ct2\/show\/NCT02048137"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0041|cit41","first-page":"S289","article-title":"Inflammatory bowel disease-induced chronic abdominal pain can be ameliorated by transcranial direct current stimulation","volume":"10","author":"Pruss","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/j.pain.0000000000000386","article-title":"Reduction of chronic abdominal pain in patientswith inflammatory bowel disease through transcranial direct current stimulation:a randomized controlled trial","volume":"157","author":"Volz","year":"2016","journal-title":"Pain"},{"issue":"6 (Supplement 1","key":"10.1002\/14651858.CD013589.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1016\/S0016-5085(18)31586-5","article-title":"Sa1762 - first-in-human study of the novel 5-HT2B receptor antagonist, Rq-00310941, demonstrated safety and tolerability both in healthy subjects and ulcerative colitis patients, with improvement of a sense of abnormal bowel movement","volume":"154","author":"Zai","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0044|cit44","unstructured":"Evaluation of the effects of lyophilized Saccharomyces Boulardii capsules on quality of life and clinical outcomes in children with inflammatory bowel disease (IBD) www.irct.ir\/trial\/32179"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0045|cit45","unstructured":"Effect of mindfulness-based cognitive therapy on quality of Life , emotional symptom , dimensions of pain, dispositional mindfulness and disease activity in patients with inflammatory bowel disease https:\/\/en.irct.ir\/trial\/46526"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0046|cit46","first-page":"S594","article-title":"A randomized, controlled trial of yoga in pediatric inflammatory bowel disease: preliminary findings","volume":"109","author":"Leiby","year":"2014","journal-title":"Nature Publishing Group"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0047|cit47","unstructured":"Dietetic efficacy of Mare's Milk for patients with chronic inflammatory bowel diseases clinicaltrials.gov\/ct2\/show\/NCT00940576"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0048|cit48","unstructured":"Mindfulness therapy in inflammatory bowel disease (Mindfulness) clinicaltrials.gov\/ct2\/show\/NCT02963246"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0049|cit49","unstructured":"Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04488198"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0050|cit50","unstructured":"Mindfulness-based Cognitive Therapy for Patients With Inflammatory Bowel Disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04646785"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0051|cit51","unstructured":"Association of functional changes in the brain and the perception of pain in patients with chronic inflammatory bowel diseases (IBD) clinicaltrials.gov\/ct2\/show\/NCT02433470"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.brs.2019.03.001","article-title":"Transcranial direct current stimulation in inflammatory bowel disease patients modifies resting-state functional connectivity: a RCT","volume":"12","author":"Neeb","year":"2019","journal-title":"Brain Stimulation"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0053|cit53","unstructured":"Hypnotherapy for IBD patients with IBS-like symptoms www.trialregister.nl\/trial\/3261"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0054|cit54","unstructured":"Can mindfulness-based cognitive therapy (a group self-help program) improve the quality of life for inflammatory bowel disease patients? www.isrctn.com\/ISRCTN27934462"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1745-6215-14-431","article-title":"The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation","volume":"14","author":"Schoultz","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0056|cit56","unstructured":"Can mindfulness-based cognitive therapy (a group self-help program) improve the quality of life for inflammatory bowel disease patients? www.isrctn.com\/ISRCTN27934462"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13063-015-0909-5","article-title":"Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial","volume":"16","author":"Schoultz","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0058|cit58","first-page":"S403","article-title":"Opiate Use in Hospitalized Patients With IBD Can Be Significantly Reduced Using a Proactive Pain Protocol: Results of a Randomized Controlled Trial","volume":"115","author":"Takakura","year":"2020","journal-title":"Official journal of the American College of Gastroenterology"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0059|cit59","first-page":"15","article-title":"Efficacy of ramosetron on irritable bowel syndrome like symptoms in patients with inactive inflammatory bowel disease-A randomized, double-blind, placebo-controlled study","volume":"32","author":"Tomita","year":"2020","journal-title":"Neurogastroenterology and motility"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0060|cit60","unstructured":"Modified Chinese medicine Granule in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 randomized, double-blind, controlled trials www.chictr.org.cn\/showprojen.aspx?proj=39139"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0061|cit61","unstructured":"A supported online self-management for symptoms of fatigue, pain and urgency\/incontinence in people with inflammatory bowel disease: the IBD-BOOST trial www.isrctn.com\/ISRCTN71618461"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0062|cit62","unstructured":"Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease (PRODUCE) clinicaltrials.gov\/ct2\/show\/NCT03301311"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0063|cit63","unstructured":"Association between functional changes in the brain and the perception of pain in patients with inflammatory bowel diseases (IBD) - measured with functional Magnetic Resonance Imaging clinicaltrials.gov\/ct2\/show\/NCT03348852"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0064|cit64","unstructured":"Nabilone use for acute pain in inflammatory bowel disease patients clinicaltrials.gov\/ct2\/show\/NCT03422861"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0065|cit65","unstructured":"Group cognitive behavioral therapy for IBD patients clinicaltrials.gov\/ct2\/show\/NCT03667586"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0066|cit66","unstructured":"Reactive vs. proactive pain control in IBD (PAIN-Sparing) clinicaltrials.gov\/ct2\/show\/NCT03798405"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0067|cit67","unstructured":"Transcranial direct current stimulation and the interaction between chronic pain and the intestinal epithelial barrier in patients with chronic inflammatory bowel diseases (IBD) clinicaltrials.gov\/ct2\/show\/NCT03825900"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA Clinical practice guidelines on the management of moderate to severe ulcerative colitis.","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013589.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"issue":"13","key":"10.1002\/14651858.CD013589.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1097\/01.MIB.0000435442.07237.a4","article-title":"The burden of comedication among patients with inflammatory bowel disease","volume":"19","author":"Buckley","year":"2013","journal-title":"Inflammatory Bowel Disease"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cgh.2014.07.057","article-title":"Prevalence of chronic narcotic use among children with inflammatory bowel disease","volume":"13","author":"Buckley","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/pai.12980","article-title":"Characteristics of NSAID-induced hypersensitivity reactions in childhood","volume":"30","author":"Cavkaytar","year":"2019","journal-title":"Pediatric Allergy and Immunology"},{"issue":"10","key":"10.1002\/14651858.CD013589.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/MIB.0b013e31829614c6","article-title":"Abdominal pain in ulcerative colitis. Inflammatory bowel diseases","volume":"19","author":"Coates","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013589.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmunity Reviews"},{"issue":"28","key":"10.1002\/14651858.CD013589.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.3748\/wjg.v20.i28.9458","article-title":"Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis","volume":"20","author":"Da Silva","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD013589.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/MIB.0000000000000207","article-title":"Abdominal pain and the neurotrophic system in ulcerative colitis","volume":"20","author":"Deberry","year":"2014","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"Journal of Crohn's & Colitis"},{"issue":"1","key":"10.1002\/14651858.CD013589.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"Journal of Crohn's & Colitis"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/flgastro-2014-100514","article-title":"A UK cost of care model for inflammatory bowel disease","volume":"6","author":"Ghosh","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0081|cit81","unstructured":"McMaster University GRADEpro GDT: GRADEpro Guideline Development Tool"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0082|cit82","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2021). The Cochrane Collaboration, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD013589.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013210.pub2","article-title":"Interventions for maintenance of surgically induced remission in Crohn\u2019s disease: a network meta-analysis","author":"Iheozor-Ejiofor","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013589.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11894-015-0466-9","article-title":"Ulcerative colitis: update on medical management","volume":"17","author":"Iskandar","year":"2015","journal-title":"Current Gastroenterology Reports"},{"issue":"11","key":"10.1002\/14651858.CD013589.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012853","article-title":"Cannabis for the treatment of Crohn's disease","author":"Kafil","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013589.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/ph3041084","article-title":"Non steroidal anti-inflammatory drugs and inflammatory bowel disease","volume":"3","author":"Klein","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012839.pub2","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","author":"Limketkai","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013589.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012680.pub2","article-title":"Adjuvant therapy with antidepressants for the management of inflammatory bowel disease","author":"Mikocka-Walus","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013589.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-019-0259-y","article-title":"Antidepressants in inflammatory bowel disease","volume":"17","author":"Drossman","year":"2020","journal-title":"Nature Reviews. Gastroenterology & Hepatologu"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0090|cit90","unstructured":"Ulcerative colitis - Evidence reviews for induction of remission in mild-to-moderate ulcerative colitis NICE guidelines [NG130]. Available at: www.nice.org.uk\/guidance\/ng130\/evidence\/induction-of-remission-in-mildtomoderate-ulcerative-colitis-pdf-6777260893"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apt.14108","article-title":"Systematic review: interventions for abdominal pain management in inflammatory bowel disease","volume":"46","author":"Norton","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"9853","key":"10.1002\/14651858.CD013589.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD013589.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/MIB.0000000000001087","article-title":"Predictors of chronic opioid use in newly diagnosed Crohn\u2019s disease","volume":"23","author":"Pauly","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0094|cit94","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2020"},{"issue":"5","key":"10.1002\/14651858.CD013589.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/1756283X12446158","article-title":"Pain management in patients with inflammatory bowel disease: insights for the clinician","volume":"5","author":"Srinath","year":"2012","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013589.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006913.pub2","article-title":"Psychological interventions for treatment of inflammatory bowel disease","author":"Timmer","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013589.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.2.4884.375","article-title":"Cortisone in ulcerative colitis; preliminary report on a therapeutic trial","volume":"2","author":"Truelove","year":"1954","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013589.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/bjaceaccp\/mkm021","article-title":"Acupuncture in pain management","volume":"7","author":"Wilkinson","year":"2007","journal-title":"Continuing Education in Anaesthesia Critical Care & Pain"},{"issue":"4","key":"10.1002\/14651858.CD013589.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013589","article-title":"Interventions for the management of abdominal pain in ulcerative colitis","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:42:30Z","timestamp":1673368950000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013589.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":99,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013589.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}